51 – 60 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1997
-
Mark
Tumour biological features of BRCA1-induced breast and ovarian cancer
(
- Contribution to journal › Article
- 1995
-
Mark
The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas
(
- Contribution to journal › Article
- 1994
-
Mark
Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line
(
- Contribution to journal › Article
-
Mark
At what age do sunburn episodes play a crucial role for the development of malignant melanoma
(
- Contribution to journal › Article
-
Mark
Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy
(
- Contribution to journal › Article
- 1993
-
Mark
Rheumatoid arthritis as a risk factor for multiple myeloma : A case-control study
(
- Contribution to journal › Article
-
Mark
MMM as second line treatment for advanced breast cancer. Evidence of cross-resistance with antracyclines
(
- Contribution to journal › Published meeting abstract
- 1992
-
Mark
Elevation of ADP-ribosylation as an indicator of mononuclear leucocyte responsiveness in breast cancer patients treated with tamoxifen
(
- Contribution to journal › Article
-
Mark
Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases-A prospective randomised placebo-controlled multicentre study
(
- Contribution to journal › Article
-
Mark
Phase II study of tauromustine in malignant glioma
(
- Contribution to journal › Article